L

LNTH

Lantheus Holdings, Inc.
HealthcareDrug Manufacturers - Specialty & Generic|NASDAQ Global Market|US

Price

$76.10

Market Cap

$4.95B

Beta

-0.14

P/E

23.8

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.50%
EPS Growth (YoY)-22.88%
Revenue CAGR 3Y+18.13%
P/E Ratio23.8
PEG Ratio
FCF Yield+7.04%
Debt / Equity0.62
Interest Coverage15.7x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for LNTH.

LNTH — Lantheus Holdings, Inc. Stock Analysis | Tessera Alpha